Saturday, October 13, 2018 Plenary Hall Meeting Room 26 Hall 1 Hall 2 Hall 3 Hall X Hall Y Hall 28 - - - - - - - - - - Advisory Council Meeting Delegates Assembly 1 Radiopharmacy/ Drug Development Trial Regulations 6 / / ASNC Recent Guidelines on Myocardial Amyloidosis, Sarcoidosis and Large Vessel Vasculitis 2 Bone & / / GEMO Management of Bone Metastases in the Era of Targeted Treatments 7 / Physics Radiomics, AI and Machine Learning in Hybrid 3 Translational Molecular & The Role of Molecular in Radiation 8 / Physics Alpha- Endoradiotherapy in Solid Tumours 4 Physics Radiomics - Image Derived Parameters in Multimodality 9 / in Cancer 5 / INMiND Neuroinflammation in Neurodegeneration 10 Drug Development / Towards New Radiopharmaceuticals for Psychiatry - - - - - - - - - - - - - - Members Assembly - - - 18:30-18:30 19:30-20:30 Opening 19:30-20:30 **Official approval of joint society pending as per date of printing 10 11
Sunday, October 14, 2018 - - 101 1 Fever of Unknown Origin 102 1 / ESPN The Role of Nuclear Medicine in Paediatric Febrile UTIs 103 2 / EAU Update on the Use of PET/CT in Testicular Cancer 104 Opening (08:00-08:15) CTE 1 / SNMMI Prostate Cancer and : Tech Guide Launch 105 - Featured PRRT - Understand & Improve 106 SPECT-CT 107 Artefacts 1 - Bone & / Multimodality imaging in Sports Medicine 108-68Ga-PSMA it is! 110 From Myocardial Perfusion to Plaque 111 Walk 1 All Around - - - - - - - 201 Plenary 1 incl. Marie Curie Lecture In Vivo Molecular Diagnosis of Cognitive Disorders: A Paradigm Change 301 2 New Guidelines in Nuclear ology 302 3 - / SIOPEN on Neuroblastoma 303 4 / ESMI New Approaches for Atherosclerois 204 Plenary 1 incl. Marie Curie Lecture In Vivo Molecular Diagnosis of Cognitive Disorders: A Paradigm Change 304 CTE 2 - Radionuclide - A Multidisciplinary Approach 305 Therapie Effects, Preclinical 306 for 177 Lu-DOTA- Octreotate 307 Artefacts 2 - / Physics Artefacts in Hybrid 308 - Mix it up, Please! 311 Walk 2 PSMA - e-walk to Success? - - - - - - - 401 3 SPECT or PET? 402 5 / / EULAR Guidelines on Vasculitis 403 6 / ISNS / EHNS What is Changing in the Sentinel Node Procedure? 404a Mini Course 1 (-) Non- Nuclear Medicine Diagnostic 404b Mini Course 2 (15:45-16:45) Lymphoscintigraphy and Sentinel Node 405 PSMA Targeting 406 Image Processing / Analysis 407 1 - Basics of 408 Special 20 Years of PET/CT in Practice 409 Targeted of Malignant Tumours 411 Walk 3 - - - - 501 4 PET/MR in Sharing Experiences 502 7 / EAN / SNMMI Trials in Dementia - Expectations on Molecular 503 8 / IASLC New Techniques for Diagnosis and Prognostication of Lung Cancer Patients 404c Mini Course 3 - ( - ) PET Patient Preparation: Artefacts 505 PSMA - Expanding Effects 506 Standardization & Calibration 507 2 - Lung Anatomy and Patterns of Lung Malignancy 508 PRRT of Neuroendocrine Tumours 509 Endocrine 510 New Trends in & Inflammation 511 Walk 4 Bone & Scintillating Bone - - *ICC = Cases **Official approval of joint society pending as per date of printing 12 13
Monday, October 15, 2018 - - 601 5 Radiopharmacy / EDQM Validation of Radioanalytical Methods 602 9 / ESVS Inside the Aorta: Vascular Inflammation, and Atherosclerosis 603 10 / ESMO Radioisotope Therapies in Prostate Cancer and Position in Oncological Treatment Paradigms 604 Presentations 1 605 It s All About Peptides 606 Radiation Exposure & Protection 607 Artefacts 3 - Advantages and Limitations of Voxelized for Intra- Arterial Liver 608 - It s in the Blood! 609 Endocrine Molecular 610 Integrating Models in MPI - From Injection to Interpretation 611 Walk 5 Instrumentation & Data Analysis - - - - - - - 701 Plenary 2 To Do, or Not to Do, that is the Question 801 6 Alpha Particle - When, Why and How? 802 11 / ATA tbc. 803 12 / EORTC Integrating PET into RECIST 704 Plenary 2 To Do, or Not to Do, that is the Question 804 (in Rooms 31-34) Technologist Walks 1-4 806 Reconstruction 807 Artefacts 4 - / Physics Amyloid 808 - GIT up! 809 Special Tomorrow s Experts Best-Ranked Papers from the Under-30s - - - - - - 901 7 Radiation Protection / Optimization of Diagnostic Reference Levels in Hybrid in Paediatric 902 13 / Drug Development / ECNP Phosphodiesterases (PDEs) in the CNS: Targets for Drug Development 903 14 / EHA PET/CT Guided Treament in Hodgkin Lymphoma 904 CTE 3 / in Dementia 905 Antibodies & Peptides: Let s Modify! 906 in PSMA - What is the Benefit? 907 3 - ESMIT Modern Insight in Medical Education 909 Radioiodine of Benign Diseases 910 29 Radiopharmacy / / Radiation Protection / EMA tbc. 911 Walk 6 Different Aspects of I - - - - - 1001 8 Different Strategies in the Management of Hepatic Metastases in NEN 1002 15 / ASNC Detecting Cardiac Microvascular Disease with PET 1003 16 Physics / EFOMP / ESR Dedicated and Low Dose Molecular 1004 CTE 4 Latest Development in PET/MR 1005 Antibodies and their Fragments 1006 Alpha-Particle Emitter 1007 4 - Lung TNM 8 and Function of the Lung MDM 1008 PSMA Ligand of Prostate Cancer 1009 Cancer - From Pathology to Personalized Treatment 1010 - Cognitive Impairment & Neuro-Degeneration 1011 Walk 7 & InflammationI - - *ICC = Cases **Official approval of joint society pending as per date of printing 14 15
Tuesday, October 16, 2018 - - 1101 9 & / Targets for Cancer Immunotherapy 1102 17 / ICRU Target Practice - Conditions for Personalized Treatment Planning in Radionuclide 1103 18 / JSNM Targeted Alpha - Prospect of Networking, Partnership, and Logistics 1104 Presentations 2 1105 AD-PD - It s in the brain! 1106 Data Analysis - Neurology 1107 Artefacts 5 - Pitfalls in Parathyroid Detection with Nuclear Medicine 1108 - Prostate - Not Just 68Ga-PSMA 1109 Other Studies Non 1110 Myocardial with SPECT and PET 1111 Walk 8 / Other Studies / Other Studies - - - - - - - 1201 Plenary 3 The Fascinating World of Molecules 1301 10 - Bone & How Much Radiology Do We Need in Bone and Multi- Modality? 1302 19 / EANO Meningioma 1303 20 / EACVI Quantification of Myocardial Blood Flow 1204 Plenary 3 The Fascinating World of Molecules 1304 Presentations 3 1305 Therapie Effects - α Emitters and PDT 1306 - Quantification & Data Analysis 1307 Artefacts 6 - Translational Molecular & Is this Uptake Pathological or is it Due to Excretion? 1308 - Lung! Lung! Lung! 1309 - Featured Scintigraphy - An Evergreen 1311 Walk 9 - - - - - - 1401 11 Update on PET/MR in 1402 21 & / AHA Early Remodelling in Cardiomyopathies - From Preclinical to 1403 22 / ETA / EUGOGO Treatment of Graves Disease (GD) in the Presence of Graves Ophthalmopathy (GO) 1404 CTE 5 / ESTRO PET/CT Radiotherapy Planning in Head & Neck Malignancies 1406 Methodologies - From Images to Absorbed Dose 1407 5 - Radiopharmacy Nanomedicine and Radiopharmaceuticals 1408 Radioligand of Neuroendocrine Tumours - Safety & Toxicity 1410 1411 Walk 10 Quality Control & Radiopharmaceutical Aspects - - - - - 1501 12 PET Guided Biopsy 1502 23 /EARL New Developments of PET/CT Guidelines and Update of the EARL Accreditation Standards 1503 24 / ETA-CRN Molecular Mechanism of Iodine Resistance and Their Implications 1504 CTE 6 - Renal 1505 Novel Tracers in 1506 Treatment Planning for Y-90 Radioembolisation 1507 6 - Lung Cancer Testing your Knowledge with Live Cases 1508 - In the Air and Beyond 1510 Myocardial - New Developments with CZT-Cameras 1511 Walk 11 Mixer - - *ICC = Cases **Official approval of joint society pending as per date of printing 16 17
Wednesday, October 17, 2018 - - 1601 13 / Myocardial 123-mIBG in Neurology Is it Ready for Prime Time? 1602 25 Radiation Protection / / / ICRP Risk Estimates for Patients Undergoing Molecular Radionuclide 1603 26 & / IFCARS Computer Assisted Image and Radioguided Intervention in Surgery and Radiology 1605 Neuroinflammation & Brain 1606 PET-CT & PET-MR 1607 Artefacts 7 - PSMA 1608 - Women ONLY! 1611 Walk 12 Different Aspects of II - - - - - - - 1701 14 Physics / Quantitative Multimodality 1801 Awards (11:45-12:15) Plenary 4 - Highlights Lecture (12:15-13:15) Closing (13:15-13:20) 1702 27 / EACVI The Potential of Dual Isotope in Nuclear Cardiology 1703 28 / ESTRO PET/CT for Radiotherapy Planning 1704 CTE 7 - / and 1804 Awards (11:45-12:15) Plenary 4 - Highlights Lecture (12:15-13:15) Closing (13:15-13:20) 1705 Radiochemistry is Cool! 1706 Miscellaneous Topics in 1709 Dementia 1710 Bone & - Featured Bone & Hybrid 1711 Walk 13 Radionuclide / Local and Systemic of Malignant Tumours - - - - - - - - - - - - - - - *ICC = Cases **Official approval of joint society pending as per date of printing 18 19